blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1692097

EP1692097 - TRICYCLIC HYDROXAMATE AND BENZAMIDE DERIVATIVES, COMPOSITIONS AND METHODS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.07.2010
Database last updated on 02.11.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): TR		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Exonhit Therapeutics SA
26, rue Brunel
75017 Paris / FR
[2006/34]
Inventor(s)01 / LEBLOND, Bertrand
111, rue Thomas Dubosc
F-76000 Rouen / FR
02 / BEAUSOLEIL, Eric
5bis, rue Chauvelot
F-75015 Paris / FR
 [2006/34]
Representative(s)Tezier Herman, Béatrice, et al
Cabinet Becker & Associés
25, rue Louis le Grand
75002 Paris / FR
[N/P]
Former [2008/45]Tezier Herman, Béatrice, et al
Cabinet Becker & Associés 25, rue Louis Le Grand
75002 Paris / FR
Former [2006/34]Tezier Herman, Béatrice, et al
Cabinet BECKER & ASSOCIES 25, rue Louis Le Grand
75002 Paris / FR
Application number, filing date04806498.410.12.2004
[2006/34]
WO2004IB04334
Priority number, dateEP2003029314312.12.2003         Original published format: EP 03293143
[2006/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005058803
Date:30.06.2005
Language:EN
[2005/26]
Type: A1 Application with search report 
No.:EP1692097
Date:23.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 30.06.2005 takes the place of the publication of the European patent application.
[2006/34]
Type: B1 Patent specification 
No.:EP1692097
Date:02.09.2009
Language:EN
[2009/36]
Search report(s)International search report - published on:EP30.06.2005
ClassificationIPC:C07C259/10, C07C233/80, C07C259/06, A61K31/167, A61P35/00
[2006/34]
CPC:
C07C259/10 (EP,US); A61P35/00 (EP); C07C233/80 (EP,US);
C07C259/06 (EP,US); C07C2602/10 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/34]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:TRICYCLISCHE HYDROXAMAT- UND BENZAMIDDERIVATE, ZUSAMMENSETZUNGEN UND VERFAHREN[2006/34]
English:TRICYCLIC HYDROXAMATE AND BENZAMIDE DERIVATIVES, COMPOSITIONS AND METHODS[2006/34]
French:DERIVES TRICYCLIQUES D'HYDROXAMATE ET DE BENZAMIDE, COMPOSITIONS ET METHODES[2006/34]
Entry into regional phase18.05.2006National basic fee paid 
18.05.2006Designation fee(s) paid 
18.05.2006Examination fee paid 
Examination procedure18.05.2006Examination requested  [2006/34]
29.09.2006Despatch of a communication from the examining division (Time limit: M04)
02.02.2007Reply to a communication from the examining division
10.09.2008Despatch of a communication from the examining division (Time limit: M04)
15.01.2009Reply to a communication from the examining division
13.02.2009Communication of intention to grant the patent
04.06.2009Fee for grant paid
04.06.2009Fee for publishing/printing paid
Opposition(s)03.06.2010No opposition filed within time limit [2010/32]
Fees paidRenewal fee
18.05.2006Renewal fee patent year 03
10.12.2007Renewal fee patent year 04
13.11.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
LT02.09.2009
PL02.09.2009
RO02.09.2009
SI02.09.2009
SK02.09.2009
TR02.09.2009
BG31.12.2009
IS02.01.2010
HU03.03.2010
[2011/44]
Former [2011/32]CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
LT02.09.2009
PL02.09.2009
RO02.09.2009
SI02.09.2009
SK02.09.2009
BG31.12.2009
IS02.01.2010
HU03.03.2010
Former [2011/15]CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
LT02.09.2009
PL02.09.2009
RO02.09.2009
SI02.09.2009
SK02.09.2009
BG31.12.2009
IS02.01.2010
Former [2010/23]CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
LT02.09.2009
PL02.09.2009
RO02.09.2009
SI02.09.2009
SK02.09.2009
IS02.01.2010
Former [2010/22]CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
LT02.09.2009
PL02.09.2009
RO02.09.2009
SI02.09.2009
IS02.01.2010
Former [2010/20]CY02.09.2009
EE02.09.2009
FI02.09.2009
LT02.09.2009
PL02.09.2009
SI02.09.2009
Former [2010/16]CY02.09.2009
FI02.09.2009
LT02.09.2009
PL02.09.2009
SI02.09.2009
Former [2010/11]FI02.09.2009
LT02.09.2009
PL02.09.2009
SI02.09.2009
Cited inInternational search[X]EP0382076  (BASF AG [DE]) [X] 1,15-17,20,21 * Claim 1; page 10, compounds 59-61. *;
 [X]WO9733856  (CIRD [FR], et al) [X] 1,15-17,21 * Claim 1; page 38, lines 39-41. *;
 [Y]WO0138322  (METHYLGENE INC [CA]) [Y] 1-21 * Abstract, claims. *;
 [XY]WO0222577  (NOVARTIS AG [CH], et al) [XY] 1-21 * Claim 1, examples. *;
 [X]WO02098363  (AGOURON PHARMA [US], et al) [X] 1,15-18,20,21 * Claim 1; examples e.g. A8, A9, A11, A13, etc. *;
 [X]  - ZACHEIS, D. ET AL., "Heteroarotinoids Inhibit Head and Neck Cancer Cell Lines ...", J. MED. CHEM., (1999), vol. 42, pages 4434 - 4445, XP002278654 [X] 1,15-17,20,21 * Page 4435, compound 6. *

DOI:   http://dx.doi.org/10.1021/jm990292i
 [Y]  - LAVOIE R ET AL, "Design and synthesis of a novel class of histone deacetylase inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (2001), vol. 11, no. 21, ISSN 0960-894X, pages 2847 - 2850, XP002954135 [Y] 1-21 * Abstract, compounds 4. *

DOI:   http://dx.doi.org/10.1016/S0960-894X(01)00552-2
by applicant   - HD, STEFFAN J. ET AL., NATURE, (2001), vol. 413, pages 739 - 744
    - HOCKLY E. ET AL., PNAS, (2003), vol. 100, no. 4, pages 2041 - 2046
    - PROC. NATL. ACAD. SCL. USA, (20020903), vol. 99, no. 18, pages 11700 - 11705
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.